menu
{ "item_title" : "Current Topics in Nonclinical Drug Development", "item_author" : [" Zbigniew W. Wojcinski", "Philip Bentley", "Pritam S. Sahota "], "item_description" : "This third volume in the series focuses on such germane issues as the weight of evidence approach, applying the 3Rs (replacement, reduction, and refinement), personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors dealing with issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students studying nonclinical drug development.Key Features: Explores the critical issues and current topics important in nonclinical drug development Deals with day-to-day issues in study design, evaluation of findings, and presentation of data Aids academicians and graduate students pursuing research related to nonclinical drug development Delves into both the art and science of nonclinical drug development and its impact on translational medicine and human safety ", "item_img_path" : "https://covers1.booksamillion.com/covers/bam/1/03/280/350/1032803509_b.jpg", "price_data" : { "retail_price" : "249.99", "online_price" : "249.99", "our_price" : "249.99", "club_price" : "249.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Current Topics in Nonclinical Drug Development|Zbigniew W. Wojcinski

Current Topics in Nonclinical Drug Development : Volume 3

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

This third volume in the series focuses on such germane issues as the weight of evidence approach, applying the 3Rs (replacement, reduction, and refinement), personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors dealing with issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students studying nonclinical drug development.

Key Features:

  • Explores the critical issues and current topics important in nonclinical drug development
  • Deals with day-to-day issues in study design, evaluation of findings, and presentation of data
  • Aids academicians and graduate students pursuing research related to nonclinical drug development
  • Delves into both the art and science of nonclinical drug development and its impact on translational medicine and human safety

This item is Non-Returnable

Details

  • ISBN-13: 9781032803500
  • ISBN-10: 1032803509
  • Publisher: CRC Press
  • Publish Date: October 2026
  • Dimensions: 10 x 7 x 0.75 inches
  • Shipping Weight: 1.71 pounds
  • Page Count: 306

Related Categories

You May Also Like...

    1

BAM Customer Reviews